Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Ying Jiang(Heilongjiang University of Chinese Medicine), Fuchu He(Beijing Proteome Research Center), Wantao Ying(Beijing Proteome Research Center), Yang Qiu(Beijing Proteome Research Center), Jinan Zhou(Fudan University), Hui‐Chuan Sun(Fudan University), Baocai Xing(Peking University), Lu Xie(Guangxi Medical University), Guangrong Qin(Institute for Systems Biology), Weimin Zhu(Obstetrics and Gynecology Hospital of Fudan University), Zesong Li(Shenzhen Second People's Hospital), Tieliu Shi(East China Normal University), Xin‐Rong Yang(Ministry of Education of the People's Republic of China), Huali Xu(Jilin University), Yanjun Sun(Beijing Proteome Research Center), Jian Zhou(Hainan Medical University), Manli Zhang(Shanghai Academy of Science & Technology), Meng Yan(Harbin Medical University), Li Zhang(Fudan University), Wei Liu(Sun Yat-sen University), Fang Tian(Beijing Proteome Research Center), Ning Chen(Wuhan Sports University), Xiaohong Qian(Beijing Proteome Research Center), Zhenyu Wu(Ministry of Education of the People's Republic of China), Jia Fan(Fudan University), Cheng Huang(Fudan University), Mingwei Liu(Beijing Proteome Research Center), Yang Zhao(Beijing Proteome Research Center), Xiao‐Dong Zhu(Fudan University), Jun Qin(Baylor College of Medicine), Yan Zhao(Dalian Medical University), Bo Hu(Fudan University), Aihua Sun(Beijing Proteome Research Center), Yin Huang(Beijing Proteome Research Center), Wei Sun(Beijing Proteome Research Center), Liangliang Ren(Sir Run Run Shaw Hospital), Mingchao Wang(Beijing Proteome Research Center), Menghuan Zhang(Shanghai Academy of Science & Technology)
Nature
February 27, 2019
Cited by 977


Related Papers